Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis
Authors:
- 3 August 2014
- journal article
- research article
- Published by Wiley in Hepatology Research
- Vol. 45 (6) , 656-662
Abstract
Aim: To assess the efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis (PVT) in patients with liver cirrhosis.Methods: A consecutive 26 cirrhotic patients with PVT were enrolled in this retrospective cohort study. The etiologies of cirrhosis were hepatitis B virus‐related, hepatitis C virus‐related, alcoholic and cryptogenic in five, 14, three and four patients, respectively. Child–Pugh grade A, B and C was noted in 13, eight and five patients, respectively. Patients were treated with 2 weeks' administration of danaparoid sodium followed by the evaluation of PVT reduction and adverse events.Results: All patients experienced reduction of PVT through the treatment. The median volume of PVT before and after treatment was 2.40 cm3 (range, 0.18–16.63) and 0.37 cm3 (range, 0–5.74), respectively. The median reduction rate of PVT volume was 77.3% (range, 18–100%). According to the reduction rate, complete reduction (CR), partial reduction (PR, ≥50%) and stable disease (SD, 3, P = 0.045). No severe adverse events such as bleeding symptoms (e.g. gastrointestinal bleeding and cerebral hemorrhage) and thrombocytopenia were encountered.Conclusion: Danaparoid sodium for the treatment of PVT in patients with liver cirrhosis was safe and effective. Therefore, anticoagulation therapy with danaparoid sodium could have potential as one of the treatment options in PVT accompanied by cirrhosis.Keywords
This publication has 27 references indexed in Scilit:
- Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularizationWorld Journal of Gastroenterology, 2012
- Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver CirrhosisJournal of Clinical Gastroenterology, 2010
- Vascular disorders of the liver # †Hepatology, 2009
- Thrombolysis via an Operatively Placed Mesenteric Catheter for Portal and Superior Mesenteric Vein Thrombosis: Report of a CaseSurgery Today, 2006
- Risk factors for thrombophilia in extrahepatic portal vein obstruction†Hepatology, 2005
- Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosisJournal of Hepatology, 2004
- Hereditary thrombophilia as a cause of Budd-Chiari syndrome: A study from Western IndiaHepatology, 2001
- Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant TherapyHepatology, 2000
- Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factorsHepatology, 2000
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973